Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Translational Medicine, Lund University, Malmö, Sweden.
Scand J Urol. 2021 Oct;55(5):361-365. doi: 10.1080/21681805.2021.1955967. Epub 2021 Jul 27.
The incidence of benign ureteroenteric strictures following radical cystectomy (RC) for urinary bladder cancer (UBC) is investigated mainly in single-centre studies from high-volume centres. The aim of this study was to evaluate the cumulative incidence of strictures and risk factors in a population-based cohort.
Data was collected from Bladder Cancer Data Base Sweden (BladderBaSe). The primary endpoint was stricture with intervention. Secondary endpoint included hydronephrosis both with/without intervention.
In total, 5,816 patients were registered as having had RC due to UBC between 1997 and 2014. After a median follow-up of 23.5 months (IQR = 9.0-63.1 months; range = 0.0-214.0 months), we found that 515 (8.9%) patients underwent intervention for stricture. Seven hundred and sixty-one (13.1%) patients were diagnosed with hydronephrosis without intervention. The cumulative incidence of strictures with intervention was 19.7% (95% CI = 16.7-23.1%) during the 17 years of follow-up. In the first year, the cumulative incidence of strictures was 5.6% (95% CI = 5.0-6.2%), and in the first 2 years 8.4% (95% CI = 7.6-9.3%). For the secondary endpoint, the cumulative incidence was 30.4% (95% CI = 26.7-33.1%) after 17 years. Only the year of RC was associated with stricture incidence in Cox regression analysis, whereas hospital cystectomy volume, patient age and patient sex were not.
Ureteroenteric strictures requiring intervention may be more common than previously reported, affecting nearly one fifth of patients who have undergone RC for UBC. The annual incidence was highest in the first 2 years after surgery but the cumulative incidence increased continuously during 17 years of follow-up.
根治性膀胱切除术(RC)治疗膀胱癌(UBC)后良性输尿管肠狭窄的发生率主要在高容量中心的单中心研究中进行了调查。本研究的目的是在基于人群的队列中评估狭窄的累积发生率和危险因素。
数据来自瑞典膀胱癌数据库(BladderBaSe)。主要终点是有干预措施的狭窄。次要终点包括有/无干预措施的肾积水。
在 1997 年至 2014 年间,共有 5816 例患者因 UBC 接受 RC 治疗。中位随访 23.5 个月(IQR = 9.0-63.1 个月;范围 = 0.0-214.0 个月)后,发现 515 例(8.9%)患者因狭窄接受了干预。761 例(13.1%)患者未接受干预即被诊断为肾积水。在 17 年的随访中,有干预措施的狭窄累积发生率为 19.7%(95%CI = 16.7-23.1%)。第 1 年狭窄的累积发生率为 5.6%(95%CI = 5.0-6.2%),第 2 年为 8.4%(95%CI = 7.6-9.3%)。对于次要终点,17 年后累积发生率为 30.4%(95%CI = 26.7-33.1%)。只有 RC 年份与 Cox 回归分析中的狭窄发生率相关,而医院膀胱切除术的量、患者年龄和患者性别均与狭窄发生率无关。
需要干预的输尿管肠狭窄可能比以前报道的更为常见,影响了近五分之一接受 RC 治疗 UBC 的患者。术后前 2 年的年发病率最高,但在 17 年的随访期间,累积发病率持续增加。